Investor Relations

Press Releases more >>
DateTitle
08/20/18Novan Announces Promising Clinical Results with SB414
08/08/18Novan Provides Business Update via 10-Q, Adopts Incentive Plan and Agrees to CEO Contract
SEC Filings more >>
Filing DateFormFiling GroupDownloads
09/07/188-KCurrent Reports Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
08/24/1843,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
08/24/1843,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
08/23/1843,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
Events more >>
There are currently no events scheduled.
Stock Information more >>
NOVN (Common Stock) $2.70 - 0.1 (3.57%)
ExchangeNASDAQ
Volume33,521
Today's Open$2.82
Previous Close$2.80
Data as of 09/21/18 4:00 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

10/21/16
Download Documentation Form 8937 Conversion of Preferred Stock to Common Stock
10/21/16
Download Documentation Form 8937 Reverse Stock Split
Presentationmore >>
DateTitle
06/20/18
Download Documentation Novan Corporate Presentation
Get help downloading or viewing the above file types
spacer
Annual Reportsmore >>
DateTitle
04/19/18
Download Documentation 2017 Annual Report
spacer
Analyst Coverage more >>
FirmAnalyst
JMP SecuritiesDonald Ellis, Pharm.D.
Piper Jaffray & Co.David Amsellem
spacer

The analysts above have initiated and are maintaining formal research coverage of Novan. Please note that any opinions, estimates or forecasts regarding Novan's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Novan or Novan's management. Novan does not by reference above or distribution of same imply endorsement of or concurrence with any analyst’s opinions, estimates, forecasts, conclusions or recommendations. Novan does not participate in the preparation of analysts’ reports and undertakes no obligation to verify or correct any information in such reports.

Transfer Agent

American Stock Transfer & Trust Company, LLC
www.amstock.com

IR Contact

Cole Ikkala
Director, Investor Relations, Capital Sourcing & Relationships
cikkala@novan.com

Media Contact

Cari Green
Director, Corporate Communications and Administration
cgreen@novan.com
E-mail Alerts

To sign up for e-mail alerts, please enter your e-mail address in the window below and click the Submit button.